Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES
|
| |
 |
Industry Insights |
|
| |
The cell and gene therapy revolution: Milestones, mindsets and the path forward
The evolving landscape of cell and gene therapies (C>s) holds transformative potential for the future of medicine. From early experimental trials to groundbreaking FDA approvals, the journey of C>s.
|
|
|
|
| |
|
|
| |
|
|
Smart Packaging – Making Way For A Surge In Drugs Demand
Enhancing CLD for complex biologics has the potential to raise expression levels, lower costs, and speed up the delivery of medicines of the next generation.
|
|
| |
|
|
| |
At CPHI Milan, TekniPlex Healthcare to Highlight New Solutions for Single-use Bioprocessing, Cell & Gene Therapies
TekniPlex Healthcare, which utilizes advanced materials science expertise to help deliver better patient outcomes, will emphasize its expertise and intellectual property related to single-use.
|
|
|
|
|
|
|
| |
|
|
CPHI Milan Announce Pharma Award finalists
CPHI Milan (8-10 October, 2024) announces the finalists for the upcoming CPHI Pharma Awards, which will be hosted on the event’s opening evening at the CPHI Celebration.
|
|
| |
|
|
| |
Enhancing Cell Count: Unveiling the Power of Precision in Cell Counting Technology in Medicine
Cell counting technology in medicine has evolved significantly, driven by the need for precise analysis of diverse cell characteristics. Cell count, cell type, size variability, and viability.
|
|
|
|
| |
|
|
| |
|
|
Nuclear Medicine In North America: Market Growth & Trends
With a 9.90% CAGR, North American nuclear medicine market, worth USD 2.05 billion in 2023, is quite rapidly advancing through AI and personalized therapies.
|
|
| |
|
|
|
